This study is looking at whether a stem cell treatment called adMSC can help people with early Alzheimer's disease or mild memory problems. adMSC uses your own stem cells, taken from a small fat sample, which are then processed and given back to you through an IV. Researchers want to see if this treatment can reduce inflammation in the brain, improve brain activity, and slow down the progression of Alzheimer's disease. To join, you need to be between 60 and 80 years old and have a diagnosis of late pre-symptomatic or mild cognitive impairment (MCI) due to Alzheimer's disease. The study is currently unclear on its recruitment status.

Study design

This is an open-label study, meaning both you and the study team will know what treatment you are receiving. It plans to enroll 12 participants.

What's involved

You will have a small fat biopsy, receive 4 infusions of stem cells over 12 weeks, and visit the clinic every 2-4 weeks for the first 4 months.

Compensation

Not stated in the trial record.

Follow-up

The study measures changes up to 169 days from the first infusion.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.